Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 190

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 190
---
 Under Rule IM -5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since we failed to complete our initial business combination by December 6, 2024, Nasdaq’s staff concluded that the we did not comply with Rule IM -5101-2and that our securities are now subject to delisting. As a result, trading in our securities on Nasdaq was effectively suspended with the open of the market on December 17, 2024, and our securities are currently eligible to trade only on the over -the -countermarkets system. We did not request a hearing in respect of the Public Warrants, SPAC Units or the SPAC Class A Ordinary Shares delisting. As of the date hereof, Nasdaq has not yet filed the Form 25 -NSEwith the SEC. We intend to apply for the trading of our securities on the over -the -countermarket after they are delisted from Nasdaq. We will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. On March21, 2025, Nasdaq filed a Form 25 -NSEin respect of APx’s Class A ordinary shares with the SEC, and the delisting of APx’s Class A ordinary shares will become effective on March31, 2025. In order to complete the delisting process with respect to APx’s units and warrants, APx expects that Nasdaq will file a Form 25 -NSEin respect of such securities with the SEC, and the delisting will become effective ten days after such Form 25 -NSEis filed. Although APx expects that it will be notified by Nasdaq prior to the filing of such Form 25 -NSE, as well as prior to the release of a press release by Nasdaq announcing the delisting event, APx is not at this time able to determine when such Form 25 -NSEwill be filed or when the delisting of APx’s units and warrants from Nasdaq will be complete. However, the filing of the Form 25 -NSEby Nasdaq and the subsequent delisting of APx’s units and warrants may occur at any time without prior notice. Despite the anticipated delisting of our securities from Nasdaq, we intend to proceed with our efforts to consummate our initial Business Combination. However, Nasdaq approval of OmnigenicsAI’s initial listing